闻泰科技再发声明：坚决反对将商业问题政治化

Core Viewpoint - The company strongly opposes the Dutch government's administrative directive against Nexperia, arguing that it politicizes commercial issues and calls for a return to rationality and the essence of business [2] Group 1: Company Position and Actions - The company, as the controlling shareholder of Nexperia, protests against the Dutch government's global operational freeze on Nexperia, claiming it is based on unfounded "national security" concerns and reflects excessive geopolitical interference [2] - The company has initiated all legal and diplomatic avenues to demand the immediate withdrawal of the Dutch government's erroneous directive and to stop systemic discrimination against Chinese enterprises [13][14] - The company emphasizes that the semiconductor industry is a product of globalization, and its future depends on collaboration rather than confrontation [14] Group 2: Contributions and Achievements - Since the acquisition of Nexperia, the company has adhered to national laws and regulations, maintaining transparency and governance [6] - Nexperia has contributed significantly to the European semiconductor supply chain, employing thousands in R&D and manufacturing centers across the Netherlands, Germany, and the UK [6] - Over the past three years, Nexperia's R&D investment has increased by over 150%, and the number of global patents has risen by nearly a thousand [6] Group 3: Financial Performance - Nexperia's revenue reached a peak of €2.36 billion in 2022, with gross margin increasing from 25% in 2020 to 42.4% in 2022 [9] - The company has achieved "zero debt" status by October 2024, having repaid all prior debts [9] - R&D investment has steadily grown from €112 million in 2019 to €284 million in 2024, with an increasing proportion of capitalized investments [9] Group 4: Governance and Legal Issues - Some foreign management at Nexperia are attempting to change the company's ownership structure through legal means, which is closely linked to the Dutch government's directive, viewed as an attempt to undermine shareholder rights and disrupt the company's governance [11][14] - The company condemns these actions as a malicious extension of external pressure [10]